Generate a tailored SOP for Dr. Corinne Linardic. Improve your application with a focused, well-structured draft.
Corinne Mary Linardic is an Associate Professor in the Department of Pediatrics, Department of Cell Biology, and Department of Pharmacology and Cancer Biology at Duke University. She is also a member of the Duke Cancer Institute. Her research primarily focuses on pediatric sarcomas, particularly rhabdomyosarcoma, which is known for being a challenging cancer to treat with high mortality rates. Linardic uses genetically defined human cell-based models and genetically engineered murine models to elucidate the genetic underpinnings of rhabdomyosarcoma, including chromosomal translocations and oncogenic RAS mutations, which contribute to tumor formation and treatment resistance. She aims to identify corrupted signaling pathways and new therapeutic targets for childhood cancers. Linardic has completed her M.D. and Ph.D. at Duke University and has held multiple fellowships, including Pediatric Hematology-Oncology at Duke University and Children's Hospital of Philadelphia. Her educational background includes Board Certification in Hematology Oncology. She is actively involved in defining drug targets for fusion-positive sarcomas and has obtained significant grants to support her research endeavors.
Duke University • Durham, NC
Position held in Pediatrics, Cell Biology, and Pharmacology & Cancer Biology.
Department of Biomedical Engineering (MS program)